Literature DB >> 23116119

Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1.

Mark A Villamil1, Qin Liang, Junjun Chen, Yong Seok Choi, Shuyu Hou, Kelvin H Lee, Zhihao Zhuang.   

Abstract

Deubiquitinating enzymes (DUBs) are important for the normal function of a number of cellular processes, including transcriptional regulation, cell cycle control, and DNA damage response. The enzymatic activity of DUB is regulated by different mechanisms. DUBs in several different families are post-translationally modified by phosphorylation. Large-scale phosphoproteomic studies of human DUBs revealed that a majority of ubiquitin-specific proteases (USPs) are phosphorylated. USP1 is a prototypical DUB that requires a specific interaction with a WD40-repeat protein, UAF1, for its catalytic activity. In this study, we show that Ser313 phosphorylation in USP1 is required for its interaction with UAF1 and for the stimulation of USP1's activity. In contrast, two other known USP1 serine phosphorylations (Ser42 and Ser67) are dispensable with respect to the activity of the USP1/UAF1 complex. An S313D phosphomimetic mutation in USP1 can substitute for Ser313 phosphorylation in promoting the formation of the USP1/UAF1 complex. We further demonstrated that CDK1 is responsible for Ser313 phosphorylation, and protein phosphatase treatment of USP1 can lead to inactivation of USP1/UAF1. An inserted domain in USP1 (amino acids 235-408) was found to interact with UAF1, and this interaction is mediated by Ser313 phosphorylation. Our findings revealed an intriguing mechanism of regulating USP1 activity that combines phosphorylation of a key serine residue in USP1 and the specific interaction of USP1 with a WD40-repeat protein UAF1. The pSer313-dependent formation of the USP1/UAF1 complex points to a new approach for inhibiting USP1 activity by disrupting the interaction between the UAF1's WD40-repeat domain and the Ser313-containing phosphopeptide in USP1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116119      PMCID: PMC3617561          DOI: 10.1021/bi300845s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  58 in total

Review 1.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

3.  Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion.

Authors:  Mariola J Edelmann; Holger B Kramer; Mikael Altun; Benedikt M Kessler
Journal:  FEBS J       Date:  2010-06       Impact factor: 5.542

Review 4.  Phosphoserine/threonine-binding domains.

Authors:  M B Yaffe; A E Elia
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

5.  A noncanonical cysteine protease USP1 is activated through active site modulation by USP1-associated factor 1.

Authors:  Mark A Villamil; Junjun Chen; Qin Liang; Zhihao Zhuang
Journal:  Biochemistry       Date:  2012-03-22       Impact factor: 3.162

6.  Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.

Authors:  Jeremy L Yap; Xiaobo Cao; Kenno Vanommeslaeghe; Kwan-Young Jung; Chander Peddaboina; Paul T Wilder; Anjan Nan; Alexander D MacKerell; W Roy Smythe; Steven Fletcher
Journal:  Org Biomol Chem       Date:  2012-03-07       Impact factor: 3.876

7.  Structural insights into the assembly and function of the SAGA deubiquitinating module.

Authors:  Nadine L Samara; Ajit B Datta; Christopher E Berndsen; Xiangbin Zhang; Tingting Yao; Robert E Cohen; Cynthia Wolberger
Journal:  Science       Date:  2010-04-15       Impact factor: 47.728

8.  Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation.

Authors:  Xiaolei Ma; Elizabeth Helgason; Qui T Phung; Clifford L Quan; Rekha S Iyer; Michelle W Lee; Krista K Bowman; Melissa A Starovasnik; Erin C Dueber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

9.  An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.

Authors:  Stephen Orlicky; Xiaojing Tang; Victor Neduva; Nadine Elowe; Eric D Brown; Frank Sicheri; Mike Tyers
Journal:  Nat Biotechnol       Date:  2010-06-27       Impact factor: 54.908

10.  Structural basis for assembly and activation of the heterotetrameric SAGA histone H2B deubiquitinase module.

Authors:  Alwin Köhler; Erik Zimmerman; Maren Schneider; Ed Hurt; Ning Zheng
Journal:  Cell       Date:  2010-04-29       Impact factor: 41.582

View more
  21 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

Review 2.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 3.  Eukaryotic Translesion DNA Synthesis on the Leading and Lagging Strands: Unique Detours around the Same Obstacle.

Authors:  Mark Hedglin; Stephen J Benkovic
Journal:  Chem Rev       Date:  2017-05-12       Impact factor: 60.622

Review 4.  Stress and DNA repair biology of the Fanconi anemia pathway.

Authors:  Simonne Longerich; Jian Li; Yong Xiong; Patrick Sung; Gary M Kupfer
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 5.  The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention.

Authors:  Mark A Villamil; Qin Liang; Zhihao Zhuang
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

6.  The WD40-repeat protein WDR-48 promotes the stability of the deubiquitinating enzyme USP-46 by inhibiting its ubiquitination and degradation.

Authors:  Molly Hodul; Rakesh Ganji; Caroline L Dahlberg; Malavika Raman; Peter Juo
Journal:  J Biol Chem       Date:  2020-06-25       Impact factor: 5.157

7.  A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.

Authors:  Qin Liang; Thomas S Dexheimer; Ping Zhang; Andrew S Rosenthal; Mark A Villamil; Changjun You; Qiuting Zhang; Junjun Chen; Christine A Ott; Hongmao Sun; Diane K Luci; Bifeng Yuan; Anton Simeonov; Ajit Jadhav; Hui Xiao; Yinsheng Wang; David J Maloney; Zhihao Zhuang
Journal:  Nat Chem Biol       Date:  2014-02-16       Impact factor: 15.040

8.  Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage.

Authors:  Anne Olazabal-Herrero; Iraia García-Santisteban; Jose Antonio Rodríguez
Journal:  Mol Cancer       Date:  2015-02-06       Impact factor: 27.401

Review 9.  USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy.

Authors:  Iraia García-Santisteban; Godefridus J Peters; Elisa Giovannetti; Jose Antonio Rodríguez
Journal:  Mol Cancer       Date:  2013-08-10       Impact factor: 27.401

Review 10.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.